First AD

Second AD

Managing AEs Associated with HMA Treatment

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Insights Video Series

Advances in the Treatment and Management of Myelodysplastic Syndrome (MDS): The Role of Oral HMAs

Guillermo Garcia-Manero, MD, reviews potential serious and common adverse effects associated with HMA treatments, shares tips for patient education to help manage these AEs, and discusses if and when a dose reduction or discontinuation may be necessary.

Diagnosing and Managing Myelodysplastic Syndrome

Treating Intermediate- and High-Risk MDS

Available and Emerging Oral HMAs

Real-World Use for Oral HMAs

The Impact of Oral HMA Treatment Options on QOL

The Role for HMAs in Lower-Risk MDS

Treating CMML and AML with HMAs